Integra LifeSciences Announces that Omnigraft(TM) Dermal Regeneration Matrix was Recognized as a Top Ten Innovation by Podiatry Today
GlobeNewswire - 32 mins ago
Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that its recently introduced product, Integra(R) Omnigraft(TM) Dermal Regeneration Matrix, has been recognized by Podiatry Today as one of the "Top Ten Innovations in Podiatry" in 2016. Podiatry Today is an award-winning, premier publication that emphasizes informative clinical features and practice management articles. Annually, Podiatry Today picks the most innovative products in the podiatric industry to showcase in their monthly publication.
IART: 84.27 (+1.30), IARTV: 65.00 (-37.45)
Integra LifeSciences Reports Second Quarter 2016 Financial Results
GlobeNewswire - Thu Jul 28, 5:00AM CDT
Revenue Increased 17.2% to $249.3 million; Organic Revenue Increased 10.7%
IART: 84.27 (+1.30)
Shares of IART Up 34.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jul 28, 12:36AM CDT
SmarTrend identified an Uptrend for Integra LifeSciences (NASDAQ:IART) on February 22nd, 2016 at $58.86. In approximately 5 months, Integra LifeSciences has returned 34.11% as of today's recent price of $78.93.
IART: 84.27 (+1.30)
Integra LifeSciences to Host Its Second Quarter 2016 Earnings Results Conference Call on July 28, 2016
GlobeNewswire - Mon Jul 11, 3:05PM CDT
Integra LifeSciences Holdings Corporation (NASDAQ:IART) will release its second quarter 2016 financial results on Thursday, July 28, 2016. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the results.
IART: 84.27 (+1.30), IARTV: 65.00 (-37.45)
Zacks.com featured highlights: Beacon Roofing Supply, Core-Mark, HNI, Integra LifeSciences and Post
Zacks Equity Research - Zacks Investment Research - Wed Jul 06, 8:30AM CDT
Zacks.com featured highlights: Beacon Roofing Supply, Core-Mark, HNI, Integra LifeSciences and Post
POST: 86.67 (+0.79), IART: 84.27 (+1.30), HNI: 52.13 (-0.42), BECN: 47.02 (-0.62), CORE: 48.96 (+0.70)
Integra LifeSciences Has Returned 30.3% Since SmarTrend Recommendation (IART)
Comtex SmarTrend(R) - Mon Jun 20, 1:06PM CDT
SmarTrend identified an Uptrend for Integra LifeSciences (NASDAQ:IART) on February 22nd, 2016 at $58.86. In approximately 4 months, Integra LifeSciences has returned 30.30% as of today's recent price of $76.69.
IART: 84.27 (+1.30)
29.5% Return Seen to Date on SmarTrend Integra LifeSciences Call (IART)
Comtex SmarTrend(R) - Fri Jun 10, 1:07PM CDT
SmarTrend identified an Uptrend for Integra LifeSciences (NASDAQ:IART) on February 22nd, 2016 at $58.86. In approximately 4 months, Integra LifeSciences has returned 29.50% as of today's recent price of $76.22.
IART: 84.27 (+1.30)
Integra (IART): Strong Revenue Growth on Global Prospects
Zacks Equity Research - Zacks Investment Research - Wed Jun 01, 7:16AM CDT
On May 31, 2016, we issued an updated research report on Plainsboro, NJ-based Integra LifeSciences Holdings Corporation (IART).
IART: 84.27 (+1.30), ANIP: 60.60 (+0.99), NEO: 8.72 (-0.40), RTRX: 17.93 (+0.40)
Integra LifeSciences Has Returned 23.6% Since SmarTrend Recommendation (IART)
Comtex SmarTrend(R) - Thu May 26, 1:24PM CDT
SmarTrend identified an Uptrend for Integra LifeSciences (NASDAQ:IART) on February 22nd, 2016 at $58.86. In approximately 3 months, Integra LifeSciences has returned 23.61% as of today's recent price of $72.75.
IART: 84.27 (+1.30)
Integra LifeSciences to Present at the Jefferies 2016 Healthcare Conference in June 2016
GlobeNewswire - Wed May 25, 3:05PM CDT
Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it will present at the following conferences in June:
IART: 84.27 (+1.30), IARTV: 65.00 (-37.45)
Integra Unveils Fin-Lock Glenoid, Boosts Shoulder Arthroplasty
Zacks Equity Research - Zacks Investment Research - Tue May 24, 7:22AM CDT
Integra LifeSciences Holdings Corporation (IART) recently launched Integra Fin-Lock Glenoid.
IART: 84.27 (+1.30), HSKA: 42.55 (+0.03), ANIP: 60.60 (+0.99), NEO: 8.72 (-0.40)
Integra LifeSciences launches Integra(R) Fin-Lock(TM) Glenoid for the Titan(TM) Modular Shoulder System
GlobeNewswire - Mon May 23, 7:30AM CDT
Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced the launch of the Integra(R) Fin-Lock(TM) Glenoid. This addition to the Titan(TM) Modular Shoulder System increases the glenoid offerings to include features intended to help maximize long-term fixation and implant longevity.
IART: 84.27 (+1.30), IARTV: 65.00 (-37.45)
Uptrend Call Working As Integra LifeSciences Stock Rises 24.3% (IART)
Comtex SmarTrend(R) - Wed May 11, 1:17PM CDT
SmarTrend identified an Uptrend for Integra LifeSciences (NASDAQ:IART) on February 22nd, 2016 at $58.86. In approximately 3 months, Integra LifeSciences has returned 24.27% as of today's recent price of $73.14.
IART: 84.27 (+1.30)
Integra LifeSciences Receives FDA Approval for Integra(R) Omnigraft(TM) Dermal Regeneration Matrix, Clearing the Way for Commercial Release
GlobeNewswire - Wed May 11, 7:30AM CDT
Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that the Company has received approval from the U.S. Food and Drug Administration (FDA) for the packaging of its new product, Integra(R) Omnigraft(TM) Dermal Regeneration Matrix, which clears the way for its commercial release. The product's unique packaging is designed for ease of handling and application in the outpatient wound care setting.
IART: 84.27 (+1.30), IARTV: 65.00 (-37.45)
Integra LifeSciences to Present at the Bank of America Merrill Lynch 2016 Health Care Conference and the UBS Global Healthcare Conference in May 2016
GlobeNewswire - Tue May 03, 3:15PM CDT
Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it will present at the following conferences in May:
IART: 84.27 (+1.30), IARTV: 65.00 (-37.45)
Integra (IART) Beats on Q1 Earnings, Grows Organically
Zacks Equity Research - Zacks Investment Research - Thu Apr 28, 12:36PM CDT
Integra LifeSciences Holdings Corporation (IART) reported adjusted earnings per share (EPS) of 74 cents in the first quarter of 2016.
IART: 84.27 (+1.30), ANIP: 60.60 (+0.99), ANIK: 49.92 (+0.70), ALQA: 1.17 (+0.04)
Integra LifeSciences Reports First Quarter 2016 Financial Results
GlobeNewswire - Wed Apr 27, 5:01AM CDT
Revenue of $236.8 million; Organic Revenue Increased 8.9%;
IART: 84.27 (+1.30)
Integra LifeSciences Provides Update for Omnigraft(TM) Commercialization Plans, Including Expectations for an Earlier Launch
GlobeNewswire - Wed Apr 27, 5:00AM CDT
Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that the Company is prepared to launch Omnigraft(TM) Dermal Regeneration Matrix in June 2016, pending receipt of final U.S. Food and Drug Administration (FDA) packaging approval.
IART: 84.27 (+1.30), IARTV: 65.00 (-37.45)